On 14 November 2024, the U.S. Centers for Medicare & Medicaid Services (CMS) issued a final Local Coverage Determination (LCD ...

(“MIMEDX” or the “Company”) today provided the following update on the Local Coverage Determinations (“LCDs”) regarding “Skin ...

LCD - Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers (L39764) Proposed LCD - Skin Substitute Grafts/Cellular and Tissue-Based ...

Read about the successful launch of a nurse-led service treating varicose veins and venous leg ulcers, a first for London.

MiMedx (MDXG) provided the following update on the Local Coverage Determinations, LCDs, regarding “Skin Substitute Grafts/Cellular and ...

The global venous ulcer treatment market is anticipated to witness substantial growth over the next decade, driven by advancements in healthcare, increasing prevalence of chronic venous diseases, and ...

Adam Mence discusses the challenges of lower limb wound management and the benefits of driving evidence-based and self-care ...

ConvaTec maintained InnovaMatrix is an excellent product delivering strong results for patients and is trusted by clinicians. The firm remains confident of securing DFU/VLU coverage and as such, ...

Continuing our series dispelling some common myths about conditions managed by nurses in primary care, Dr Peter ...

The latest market analysis reveals a promising outlook for the global traditional wound management market, which saw an increase from USD 5,059.1 million in 2022 to USD 5,185.6 million in 2023. With a ...

Company reports third sequential quarter of record growth, contributing to a record total of $199.0 million in revenue for the first nine-months ...